(Q38325827)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Carmona MC

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Louche K

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Nibbelink M

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Prunet B

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Bross A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Desbazeille M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Dacquet C

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Renard P

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Pénicaud L

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

English

0 references

publication date

1 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

864-871

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

Differentiating members of the thiazolidinedione class: a focus on efficacy

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Adipogenesis: forces that tip the scales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Re-emergence of fibrates in the management of dyslipidemia and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Lipid extraction of tissues with a low-toxicity solvent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Effects of the obese gene product on body weight regulation in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

inferred from DOI database lookup

7 January 2021

based on heuristic

The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

inferred from DOI database lookup

7 January 2021

based on heuristic

Muscle fatty acid oxidative capacity is a determinant of whole body fat oxidation in elderly people

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802943

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.IJO.0802943

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15917863%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 January 2020

1002080567

0 references

1 reference